Alx oncology to report second quarter 2025 financial results on august 12, 2025

South san francisco, calif., aug. 05, 2025 (globe newswire) -- alx oncology holdings inc., ("alx oncology" or the "company") (nasdaq: alxo), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients' lives, today announced plans to report its second quarter 2025 financial results and a business update on tuesday, august 12th, 2025, after market close.
ALXO Ratings Summary
ALXO Quant Ranking